Collegium Pharmaceutical Total Assets 2014-2019 | COLL

Collegium Pharmaceutical total assets from 2014 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Collegium Pharmaceutical Annual Total Assets
(Millions of US $)
2018 $291
2017 $136
2016 $162
2015 $98
2014 $5
2013 $9
Collegium Pharmaceutical Quarterly Total Assets
(Millions of US $)
Q2 2019 $302
Q1 2019 $294
Q4 2018 $291
Q3 2018 $647
Q2 2018 $673
Q1 2018 $696
Q4 2017 $136
Q3 2017 $123
Q2 2017 $125
Q1 2017 $140
Q4 2016 $162
Q3 2016 $99
Q2 2016 $120
Q1 2016 $136
Q4 2015 $98
Q3 2015 $107
Q2 2015 $114
Q1 2015 $47
Q4 2014 $5
Q3 2014 $0
Q2 2014 $0
Q1 2014 $0
Q4 2013 $9
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.392B $0.280B
Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171, COL-003 and COL-172 which are in different clinical trial. It developed a formulation platform technology, DETERx, for the treatment of chronic pain. Collegium Pharmaceutical Inc. is based in CUMBERLAND, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $58.854B 36.25
Astellas Pharma (ALPMY) Japan $27.542B 13.12
Takeda Pharmaceutical (TAK) Japan $26.873B 8.39
UCB SA (UCBJF) Belgium $14.267B 0.00
Merck (MKGAF) Germany $14.152B 19.31
Eisai (ESALY) Japan $14.058B 24.17
Grifols, S.A (GRFS) Spain $14.054B 17.93
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $9.261B 0.00
Ionis Pharmaceuticals (IONS) United States $8.867B 19.12
IPSEN SA ADR (IPSEY) France $8.529B 0.00
Sage Therapeutics (SAGE) United States $8.290B 0.00
Catalent (CTLT) United States $7.406B 29.32
Jazz Pharmaceuticals (JAZZ) Ireland $7.388B 9.72
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.022B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.044B 18.13
United Therapeutics (UTHR) United States $3.692B 0.00
FibroGen (FGEN) United States $3.560B 89.04
Nektar Therapeutics (NKTR) United States $3.523B 0.00
Evotec AG (EVTCY) Germany $3.399B 46.53
Taro Pharmaceutical Industries (TARO) Israel $3.150B 11.29
Tilray (TLRY) Canada $2.976B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.776B 63.65
PTC Therapeutics (PTCT) United States $2.270B 0.00
Portola Pharmaceuticals (PTLA) United States $2.059B 0.00
Xencor (XNCR) United States $2.037B 44.42
Zogenix (ZGNX) United States $1.840B 0.00
Heron Therapeutics (HRTX) United States $1.676B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.553B 15.57
Corcept Therapeutics (CORT) United States $1.548B 21.28
Pacira Pharmaceuticals (PCRX) United States $1.547B 56.30
Ironwood Pharmaceuticals (IRWD) United States $1.505B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.391B 22.95
Radius Health (RDUS) United States $1.320B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.283B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.052B 0.00
Aerie Pharmaceuticals (AERI) United States $0.994B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.975B 4.35
ArQule (ARQL) United States $0.957B 0.00
TherapeuticsMD (TXMD) United States $0.929B 0.00
Endo (ENDP) Ireland $0.874B 1.54
Karyopharm Therapeutics (KPTI) United States $0.725B 0.00
Concordia (CXRXF) Canada $0.681B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.674B 0.00
Lannett Co Inc (LCI) United States $0.566B 5.96
Flexion Therapeutics (FLXN) United States $0.554B 0.00
Akebia Therapeutics (AKBA) United States $0.548B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.544B 0.00
Organogenesis Holdings (ORGO) United States $0.542B 0.00
Translate Bio (TBIO) United States $0.511B 0.00
Aptorum Group (APM) China $0.488B 0.00
ImmunoGen (IMGN) United States $0.472B 0.00
Siga Technologies (SIGA) United States $0.462B 1.08
Innate Pharma SA (IPHYF) France $0.455B 0.00
Indivior (INVVY) United States $0.453B 1.64
Dova Pharmaceuticals (DOVA) United States $0.446B 0.00
Dermira (DERM) United States $0.438B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.428B 19.47
ChemoCentryx (CCXI) United States $0.421B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.416B 0.00
DURECT (DRRX) United States $0.372B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.362B 0.00
Harpoon Therapeutics (HARP) United States $0.348B 0.00
OptiNose (OPTN) United States $0.335B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.311B 0.00
Ardelyx (ARDX) United States $0.306B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.293B 0.00
CV Sciences (CVSI) United States $0.289B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.285B 0.00
Rafael Holdings (RFL) United States $0.283B 0.00
Xeris Pharmaceuticals (XERS) United States $0.279B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.274B 0.00
Recro Pharma (REPH) United States $0.263B 0.00
Concert Pharmaceuticals (CNCE) United States $0.262B 0.00
KalVista Pharmaceuticals (KALV) United States $0.258B 0.00
Molecular Templates (MTEM) United States $0.229B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.216B 0.00
Calithera Biosciences (CALA) United States $0.213B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.211B 0.00
Ocular Therapeutix (OCUL) United States $0.203B 0.00
GlycoMimetics (GLYC) United States $0.196B 0.00
Nature's Sunshine Products (NATR) United States $0.189B 31.55
CannTrust Holdings (CTST) Canada $0.180B 0.00
Generex Biotechnology (GNBT) United States $0.176B 0.00
Redhill Biopharma (RDHL) Israel $0.167B 0.00
IMV INC (IMV) Canada $0.164B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
MEI Pharma (MEIP) United States $0.143B 0.00
ElectroCore (ECOR) United States $0.141B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.133B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.124B 0.00
Cardiome Pharma (CORV) Canada $0.123B 0.00
Jounce Therapeutics (JNCE) United States $0.113B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Majesco Entertainment (PTE) United States $0.108B 0.00
Mast Therapeutics (SVRA) United States $0.104B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.104B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.099B 0.00
Genocea Biosciences (GNCA) United States $0.094B 0.00
AgeX Therapeutics (AGE) United States $0.090B 0.00
Neos Therapeutics (NEOS) United States $0.090B 0.00
Iterum Therapeutics (ITRM) Ireland $0.089B 0.00
Aquestive Therapeutics (AQST) United States $0.087B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.086B 0.00
RENEURON GP (RNUGF) United Kingdom $0.084B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Nivalis Therapeutics (ALPN) United States $0.081B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.077B 29.53
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
Natural Alternatives (NAII) United States $0.074B 7.39
Lipocine (LPCN) United States $0.073B 0.00
Novan (NOVN) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.071B 0.00
Jaguar Animal Health (JAGX) United States $0.068B 0.00
Aclaris Therapeutics (ACRS) United States $0.067B 0.00
Infinity Pharmaceuticals (INFI) United States $0.067B 0.00
Otonomy (OTIC) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.064B 0.00
China SXT Pharmaceuticals (SXTC) China $0.059B 0.00
Capnia (SLNO) United States $0.058B 0.00
CTI BioPharma (CTIC) United States $0.050B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.048B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 1.62
Adamis Pharmaceuticals (ADMP) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Melinta Therapeutics (MLNT) United States $0.044B 0.00
India Globalization Capital (IGC) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
Opexa Therapeutics (ACER) United States $0.035B 0.00
Bio-Path Holdings (BPTH) United States $0.034B 0.00
PharmAthene (ALT) United States $0.032B 0.00
Biomerica (BMRA) United States $0.031B 0.00
IsoRay (ISR) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Heat Biologics (HTBX) United States $0.020B 0.00
Achieve Life Sciences (ACHV) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Vical (BBI) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Onconova Therapeutics (ONTX) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00